The more I think about it and the more times I read this

New Post Public Reply Private Reply Replies (1) Message Board
AlanC AlanC #59

The more I think about it and the more times I read this report the more convinced I am that this report was started for a very important reason.  No doubt the elimination by the DTCC of the stock borrow program was a part of it.  Now, Ted I'm sure documents his weekly contact with the transfer agent as to the exact number of shares on deposit at the DTCC before putting out this report: https://www.otciq.com/otciq/ajax/showFinancia...?id=118224

Anyone who owns shares of GNCP has seen these put out week after week.  So now the company after much good news still sees its stock being manipulated and the market cap remains at an ridiculously low value.  What might I do if I held a large number of shares?

I would pull my shares in certificate form and my brokerage firm better be able to deliver every single share or else I will own that firm.  Once those shares leave the DTCC and that number on deposit starts going down they will not be able to hide the FTD's and the chit will truly hit the fan.  Money will pour into GNCP as the whales and the sharks  will both know exactly what is going on.  The SEC can't blame management as this was not caused by them it was caused by angry noteholders who believed in the company and owned shares.

These noteholders were abused and called names by many and those same folks claimed they had sold all their shares when they had not.  Now they were exerting their rights to show they were not the ones hurting the company as claimed by getting their shares in certificate form to prove their point.

Can you imagine a situation where several individual shareholders own more shares than are on deposit at the DTCC according to the transfer agent?

Remember if GNCP wins, all the sisters win as well and a huge transfer of wealth takes place.  Go GNCP!!!

GNCC Capital Inc. (GNCP) Stock Research Links

GNCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

transcosmos Secures Special Jury Award for Outstanding Strategy

Updated Category News Views 157

Transcosmos Achieves Recognition at Contact Center Awards Recognized for clear, goal-oriented strategy working together with clients. TOKYO /PRNewswire/ -- transcosmos is thrilled to share that the company has been awarded the Special Jury Award in the Strategy category at the Contact Center Awards 2025. This prestigious event is sponsored by the Editorial Office of...

Continue Reading
HCW Biologics Partners with WY Biotech for Innovative Licensing Deal

Updated Category News Views 121

HCW Biologics Collaborates with WY Biotech on a Licensing Agreement HCW Biologics has taken an exciting step forward by entering into a license agreement with WY Biotech for a transformative preclinical immunotherapeutic product candidate. This partnership positions both companies to harness innovative technologies in the biopharmaceutical landscape. Financial Aspects of...

Continue Reading
Bucked Up® Unveils Hunt: Orange Cream—Limited Edition

Updated Category News Views 14

The Buzz Behind Bucked Up®'s Limited-Edition Flavor You know, there's caffeine, and then there's Bucked Up®'s caffeine kick—it’s a whole different animal. But now they’ve spiced things up a notch with their new Hunt: Orange Cream flavor. It’s plastered on every product from their line, from Bucked Up® to the wacky-named Woke AF®. Feels like they’re saying,...

Continue Reading
Transform Your Investment: The Growth of SPS Commerce Over Time

Updated Category News Views 53

The Impressive Growth of SPS Commerce SPS Commerce (NASDAQ: SPSC) has carved out a strong position in the market, consistently providing remarkable returns. Over the last 15 years, this company has outpaced average market growth by a staggering 13.26% each year, resulting in an average annual return of 25.11%. As of now, SPS Commerce enjoys a robust market capitalization...

Continue Reading
Exploring QIAGEN's Commitment to Newborn Genomic Sequencing

Updated Category News Views 106

Innovating Genomic Sequencing for Newborns QIAGEN (NYSE: QGEN) is making significant strides in the field of genomic medicine by partnering with Genomics England on a remarkable initiative aimed at sequencing the genomes of newborns. This pioneering effort seeks to screen for over 200 genetic conditions, facilitating early diagnosis and intervention for rare health...

Continue Reading